A detailed history of Citigroup Inc transactions in Globus Medical Inc stock. As of the latest transaction made, Citigroup Inc holds 48,164 shares of GMED stock, worth $3.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,164
Previous 39,942 20.58%
Holding current value
$3.94 Million
Previous $2.74 Million 25.96%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$67.08 - $73.92 $551,531 - $607,770
8,222 Added 20.58%
48,164 $3.45 Million
Q2 2024

Aug 12, 2024

SELL
$49.79 - $68.85 $18,770 - $25,956
-377 Reduced 0.94%
39,942 $2.74 Million
Q1 2024

May 10, 2024

BUY
$51.15 - $56.52 $508,942 - $562,374
9,950 Added 32.76%
40,319 $2.16 Million
Q4 2023

Feb 09, 2024

SELL
$43.79 - $55.14 $27,149 - $34,186
-620 Reduced 2.0%
30,369 $1.62 Million
Q3 2023

Nov 09, 2023

SELL
$49.1 - $62.37 $351,801 - $446,881
-7,165 Reduced 18.78%
30,989 $1.54 Million
Q2 2023

Aug 10, 2023

BUY
$52.61 - $59.54 $722,230 - $817,365
13,728 Added 56.2%
38,154 $2.27 Million
Q1 2023

May 11, 2023

BUY
$51.83 - $79.63 $259,357 - $398,468
5,004 Added 25.76%
24,426 $1.38 Million
Q4 2022

Feb 09, 2023

SELL
$58.4 - $75.53 $1.26 Million - $1.63 Million
-21,583 Reduced 52.64%
19,422 $1.44 Million
Q3 2022

Nov 10, 2022

BUY
$55.32 - $67.54 $1.41 Million - $1.72 Million
25,532 Added 165.01%
41,005 $2.44 Million
Q2 2022

Aug 10, 2022

SELL
$53.08 - $81.37 $457,178 - $700,839
-8,613 Reduced 35.76%
15,473 $869,000
Q1 2022

May 12, 2022

SELL
$63.68 - $75.54 $333,555 - $395,678
-5,238 Reduced 17.86%
24,086 $1.78 Million
Q4 2021

Feb 10, 2022

BUY
$62.62 - $79.92 $87,793 - $112,047
1,402 Added 5.02%
29,324 $2.12 Million
Q3 2021

Nov 10, 2021

BUY
$76.41 - $84.06 $2.13 Million - $2.35 Million
27,922 New
27,922 $2.14 Million

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.3B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.